Faced with strong competition and pressure to reduce costs across the healthcare sector, medical device manufacturers are banking on growth through breakthroughs in innovation and engineering This is also confirmed by a study by Forbes and KPMG in 2015, in which companies were asked about their strategic priorities for the
No takes yet. Share an insight, caveat, or question.
Schönberger et al. (2017) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: